Neurizon Therapeutics Limited (ASX:NUZ)

Neurizon Therapeutics Revenue

Neurizon Therapeutics had revenue of 1.53M AUD in the half year ending December 31, 2024, with 58.65% growth. This brings the company's revenue in the last twelve months to 1.52M, up 97.96% year-over-year. In the fiscal year ending June 30, 2024, Neurizon Therapeutics had annual revenue of 841.71K, down -3.66%.

• Revenue (ttm): 1.52M
• Revenue Growth: +97.96%
• P/S Ratio: 43.85
• Revenue / Employee: 378.95K
• Employees: 4
• Market Cap: 66.46M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	841.71K	-31.94K	-3.66%
Jun 30, 2023	873.65K	-3.64M	-80.63%
Jun 30, 2022	4.51M	853.24K	23.33%
Jun 30, 2021	3.66M	-463.19K	-11.24%
Jun 30, 2020	4.12M	-226.64K	-5.21%